GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ABL Diagnostics (XPAR:ABLD) » Definitions » 12-1 Month Momentum %

ABL Diagnostics (XPAR:ABLD) 12-1 Month Momentum % : -36.25% (As of Jun. 09, 2024)


View and export this data going back to 1989. Start your Free Trial

What is ABL Diagnostics 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-09), ABL Diagnostics's 12-1 Month Momentum % is -36.25%.

The industry rank for ABL Diagnostics's 12-1 Month Momentum % or its related term are showing as below:

XPAR:ABLD's 12-1 Month Momentum % is ranked worse than
75.81% of 645 companies
in the Healthcare Providers & Services industry
Industry Median: -11.92 vs XPAR:ABLD: -36.25

Competitive Comparison of ABL Diagnostics's 12-1 Month Momentum %

For the Health Information Services subindustry, ABL Diagnostics's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ABL Diagnostics's 12-1 Month Momentum % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ABL Diagnostics's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where ABL Diagnostics's 12-1 Month Momentum % falls into.



ABL Diagnostics  (XPAR:ABLD) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ABL Diagnostics  (XPAR:ABLD) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


ABL Diagnostics 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of ABL Diagnostics's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


ABL Diagnostics (XPAR:ABLD) Business Description

Traded in Other Exchanges
N/A
Address
72c, rue de, WOIPPY, Thionville, FRA, 57140
ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.

ABL Diagnostics (XPAR:ABLD) Headlines

No Headlines